Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors

Smoking Cessation and Alcohol Use Among Cancer Survivors: Investigating the Efficacy of a Mindfulness-Based Intervention

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

The primary aim of this study is to test the efficacy of MBRP-SA compared with standard care among cancer survivors, explore potential moderators, mechanisms, and predictors of treatment effects, and evaluate implementation outcomes to guide future adoption of MBRP-SA.

Inclusion Criteria:

• ≥18 years old
• History of a cancer diagnosis at any point in lifetime
• Smoked ≥1 cigarette/day in past month
• At least one binge drinking episode in past month or exceeds weekly drinking limits
• Motivated to quit smoking and modify alcohol use in next 30 days
• Valid home address in Florida
• English-speaking, reading, and writing ability

Exclusion Criteria:

• Pregnancy or lactation
• Active psychotic disorder
• History of severe alcohol withdrawal
• Current use of tobacco cessation medication or other treatments to quit smoking
• End-of-life or hospice care
• Household member already enrolled